MiR-210: More than a silent player in hypoxia

Cecilia Devlin, Simona Greco, Fabio Martelli, Mircea Ivan

Research output: Contribution to journalArticle

175 Citations (Scopus)

Abstract

Multiple studies have consistently established that miR (microRNA)-210 induction is a feature of the hypoxic response in both normal and transformed cells. Here, we discuss the emerging biochemical functions of this miRNA and anticipate potential clinical applications. miR-210 is a robust target of hypoxia-inducible factor, and its overexpression has been detected in a variety of cardiovascular diseases and solid tumors. High levels of miR-210 have been linked to an in vivo hypoxic signature and associated with adverse prognosis in cancer patients. A wide spectrum of miR-210 targets have been identified, with roles in mitochondrial metabolism, angiogenesis, DNA repair, and cell survival. Such targets may broadly affect the evolution of tumors and other pathological settings, such as ischemic disorders. Harnessing the knowledge of miR-210's actions may lead to novel diagnostic and therapeutic approaches.

Original languageEnglish
Pages (from-to)94-100
Number of pages7
JournalIUBMB Life
Volume63
Issue number2
DOIs
StatePublished - Feb 2011

Fingerprint

MicroRNAs
Tumors
Neoplasms
Metabolism
DNA Repair
Hypoxia
Cell Survival
Repair
Cardiovascular Diseases
Cells
DNA

Keywords

  • apoptosis
  • cancer
  • hypoxia
  • ischemia
  • metabolism
  • microRNA
  • miR-210
  • mitochondria

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Clinical Biochemistry
  • Molecular Biology
  • Genetics

Cite this

MiR-210 : More than a silent player in hypoxia. / Devlin, Cecilia; Greco, Simona; Martelli, Fabio; Ivan, Mircea.

In: IUBMB Life, Vol. 63, No. 2, 02.2011, p. 94-100.

Research output: Contribution to journalArticle

Devlin, C, Greco, S, Martelli, F & Ivan, M 2011, 'MiR-210: More than a silent player in hypoxia', IUBMB Life, vol. 63, no. 2, pp. 94-100. https://doi.org/10.1002/iub.427
Devlin, Cecilia ; Greco, Simona ; Martelli, Fabio ; Ivan, Mircea. / MiR-210 : More than a silent player in hypoxia. In: IUBMB Life. 2011 ; Vol. 63, No. 2. pp. 94-100.
@article{3d0c22661bac4cc5b01db33e304e0b7b,
title = "MiR-210: More than a silent player in hypoxia",
abstract = "Multiple studies have consistently established that miR (microRNA)-210 induction is a feature of the hypoxic response in both normal and transformed cells. Here, we discuss the emerging biochemical functions of this miRNA and anticipate potential clinical applications. miR-210 is a robust target of hypoxia-inducible factor, and its overexpression has been detected in a variety of cardiovascular diseases and solid tumors. High levels of miR-210 have been linked to an in vivo hypoxic signature and associated with adverse prognosis in cancer patients. A wide spectrum of miR-210 targets have been identified, with roles in mitochondrial metabolism, angiogenesis, DNA repair, and cell survival. Such targets may broadly affect the evolution of tumors and other pathological settings, such as ischemic disorders. Harnessing the knowledge of miR-210's actions may lead to novel diagnostic and therapeutic approaches.",
keywords = "apoptosis, cancer, hypoxia, ischemia, metabolism, microRNA, miR-210, mitochondria",
author = "Cecilia Devlin and Simona Greco and Fabio Martelli and Mircea Ivan",
year = "2011",
month = "2",
doi = "10.1002/iub.427",
language = "English",
volume = "63",
pages = "94--100",
journal = "IUBMB Life",
issn = "1521-6543",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - MiR-210

T2 - More than a silent player in hypoxia

AU - Devlin, Cecilia

AU - Greco, Simona

AU - Martelli, Fabio

AU - Ivan, Mircea

PY - 2011/2

Y1 - 2011/2

N2 - Multiple studies have consistently established that miR (microRNA)-210 induction is a feature of the hypoxic response in both normal and transformed cells. Here, we discuss the emerging biochemical functions of this miRNA and anticipate potential clinical applications. miR-210 is a robust target of hypoxia-inducible factor, and its overexpression has been detected in a variety of cardiovascular diseases and solid tumors. High levels of miR-210 have been linked to an in vivo hypoxic signature and associated with adverse prognosis in cancer patients. A wide spectrum of miR-210 targets have been identified, with roles in mitochondrial metabolism, angiogenesis, DNA repair, and cell survival. Such targets may broadly affect the evolution of tumors and other pathological settings, such as ischemic disorders. Harnessing the knowledge of miR-210's actions may lead to novel diagnostic and therapeutic approaches.

AB - Multiple studies have consistently established that miR (microRNA)-210 induction is a feature of the hypoxic response in both normal and transformed cells. Here, we discuss the emerging biochemical functions of this miRNA and anticipate potential clinical applications. miR-210 is a robust target of hypoxia-inducible factor, and its overexpression has been detected in a variety of cardiovascular diseases and solid tumors. High levels of miR-210 have been linked to an in vivo hypoxic signature and associated with adverse prognosis in cancer patients. A wide spectrum of miR-210 targets have been identified, with roles in mitochondrial metabolism, angiogenesis, DNA repair, and cell survival. Such targets may broadly affect the evolution of tumors and other pathological settings, such as ischemic disorders. Harnessing the knowledge of miR-210's actions may lead to novel diagnostic and therapeutic approaches.

KW - apoptosis

KW - cancer

KW - hypoxia

KW - ischemia

KW - metabolism

KW - microRNA

KW - miR-210

KW - mitochondria

UR - http://www.scopus.com/inward/record.url?scp=79952137486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952137486&partnerID=8YFLogxK

U2 - 10.1002/iub.427

DO - 10.1002/iub.427

M3 - Article

C2 - 21360638

AN - SCOPUS:79952137486

VL - 63

SP - 94

EP - 100

JO - IUBMB Life

JF - IUBMB Life

SN - 1521-6543

IS - 2

ER -